Structures of translationally inactive mammalian ribosomes
- Harvard Medical School, United States
- MRC Laboratory of Molecular Biology, United Kingdom
Abstract
The cellular levels and activities of ribosomes directly regulate gene expression during numerous physiological processes. The mechanisms that globally repress translation are incompletely understood. Here, we use electron cryomicroscopy to analyze inactive ribosomes isolated from mammalian reticulocytes, the penultimate stage of red blood cell differentiation. We identify two types of ribosomes that are translationally repressed by protein interactions. The first comprises ribosomes sequestered with elongation factor 2 (eEF2) by SERPINE mRNA binding protein 1 (SERBP1) occupying the ribosomal mRNA entrance channel. The second type are translationally repressed by a novel ribosome-binding protein, interferon-related developmental regulator 2 (IFRD2), which spans the P and E sites and inserts a C-terminal helix into the mRNA exit channel to preclude translation. IFRD2 binds ribosomes with a tRNA occupying a noncanonical binding site, the 'Z site', on the ribosome. These structures provide functional insights into how ribosomal interactions may suppress translation to regulate gene expression.
Data availability
All cryo-EM maps and models have been deposited in EMDB under accession codes 9234, 9235, 9236, 9237, 9239, 9240, 9241 and 9242. All models have been deposited in PDB under accession codes 6MTB, 6MTC, 6MTD and 6MTE.
-
Data from: Structures of translationally inactive mammalian ribosomesPublicly available at the EMBL-EBI Protein Data Bank (accession no: EMD-9234).
-
Data from: Structures of translationally inactive mammalian ribosomesPublicly available at the EMBL-EBI Protein Data Bank (accession no: EMD-9235).
-
Data from: Structures of translationally inactive mammalian ribosomesPublicly available at the EMBL-EBI Protein Data Bank (accession no: EMD-9236).
-
Data from: Structures of translationally inactive mammalian ribosomesPublicly available at the EMBL-EBI Protein Data Bank (accession no: EMD-9237).
-
Data from: Structures of translationally inactive mammalian ribosomesPublicly available at the EMBL-EBI Protein Data Bank (accession no: EMD-9239).
-
Data from: Structures of translationally inactive mammalian ribosomesPublicly available at the EMBL-EBI Protein Data Bank (accession no: EMD-9240).
-
Data from: Structures of translationally inactive mammalian ribosomesPublicly available at the EMBL-EBI Protein Data Bank (accession no: EMD-9241).
-
Data from: Structures of translationally inactive mammalian ribosomesPublicly available at the EMBL-EBI Protein Data Bank (accession no: EMD-9242).
-
Data from: Structures of translationally inactive mammalian ribosomesPublicly available at the RCSB Protein Data Bank (accession no: 6MTB).
-
Data from: Structures of translationally inactive mammalian ribosomesPublicly available at the RCSB Protein Data Bank (accession no: 6MTC).
-
Data from: Structures of translationally inactive mammalian ribosomesPublicly available at the RCSB Protein Data Bank (accession no: 6MTD).
-
Data from: Structures of translationally inactive mammalian ribosomesPublicly available at the RCSB Protein Data Bank (accession no: 6MTE).
Article and author information
Author details
Funding
Harvard Medical School (N/A)
- Alan Brown
- Matthew R Baird
- Matthew CJ Yip
- Sichen Shao
International Retinal Research Foundation (N/A)
- Alan Brown
E. Matilda Ziegler Foundation for the Blind (N/A)
- Alan Brown
Charles H. Hood Foundation (N/A)
- Sichen Shao
Richard and Susan Smith Family Foundation (N/A)
- Sichen Shao
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Copyright
© 2018, Brown et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 8,770
- views
-
- 1,131
- downloads
-
- 115
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Structures of translationally inactive mammalian ribosomes
eLife 7:e40486.
https://doi.org/10.7554/eLife.40486
Further reading
-
- Biochemistry and Chemical Biology
- Structural Biology and Molecular Biophysics
African trypanosomes are the causative agents of neglected tropical diseases affecting both humans and livestock. Disease control is highly challenging due to an increasing number of drug treatment failures. African trypanosomes are extracellular, blood-borne parasites that mainly rely on glycolysis for their energy metabolism within the mammalian host. Trypanosomal glycolytic enzymes are therefore of interest for the development of trypanocidal drugs. Here, we report the serendipitous discovery of a camelid single-domain antibody (sdAb aka Nanobody) that selectively inhibits the enzymatic activity of trypanosomatid (but not host) pyruvate kinases through an allosteric mechanism. By combining enzyme kinetics, biophysics, structural biology, and transgenic parasite survival assays, we provide a proof-of-principle that the sdAb-mediated enzyme inhibition negatively impacts parasite fitness and growth.
-
- Structural Biology and Molecular Biophysics
The relationship between protein dynamics and function is essential for understanding biological processes and developing effective therapeutics. Functional sites within proteins are critical for activities such as substrate binding, catalysis, and structural changes. Existing computational methods for the predictions of functional residues are trained on sequence, structural, and experimental data, but they do not explicitly model the influence of evolution on protein dynamics. This overlooked contribution is essential as it is known that evolution can fine-tune protein dynamics through compensatory mutations either to improve the proteins’ performance or diversify its function while maintaining the same structural scaffold. To model this critical contribution, we introduce DyNoPy, a computational method that combines residue coevolution analysis with molecular dynamics simulations, revealing hidden correlations between functional sites. DyNoPy constructs a graph model of residue–residue interactions, identifies communities of key residue groups, and annotates critical sites based on their roles. By leveraging the concept of coevolved dynamical couplings—residue pairs with critical dynamical interactions that have been preserved during evolution—DyNoPy offers a powerful method for predicting and analysing protein evolution and dynamics. We demonstrate the effectiveness of DyNoPy on SHV-1 and PDC-3, chromosomally encoded β-lactamases linked to antibiotic resistance, highlighting its potential to inform drug design and address pressing healthcare challenges.
